Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study
Primary Purpose
Mild Cognitive Impairment, So Stated, Cocaine Use Disorder
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Occupational therapy-based cognitive rehabilitation
Psychoeducation/games
Sponsored by

About this trial
This is an interventional treatment trial for Mild Cognitive Impairment, So Stated focused on measuring Cocaine, Cognitive Impairment, Cognitive Rehabilitation
Eligibility Criteria
Inclusion Criteria:
- Age 18-65
- Primary cocaine use disorder (based on DSM-5 criteria) and in at least 3 months of remission
- At least mild cognitive impairment, defined as = or > 1.5 standard deviations impairment on any 2 performance-based neurocognitive measures
- Needing to change quality of life, defined as self-identifying at least 2 life areas as needing to change on the Drug User Quality of Life Scale
- A Veteran at the San Francisco Veterans Affairs Medical Center
- Currently receiving weekly drug counseling (individual or group; at least 1 hour/week) through an outpatient substance use disorder treatment program
Exclusion Criteria:
- Inability to speak, read, write, and understand English
- Inadequate hearing or vision
- Concurrent substance use disorder (except tobacco or caffeine) not in at least 3 months of remission
- A psychiatric disorder that will interfere with study participation or will make participation hazardous (e.g., psychosis, suicidal or homicidal ideations, severe anxiety)
- A depressive disorder classified as severe, defined as a Beck Depression Inventory-II score >29
- Current diagnosis of a bipolar disorder needing acute inpatient psychiatric hospitalization
- Currently symptomatic from attention-deficit/hyperactivity disorder (DSM-5 criteria)
- Any learning disorder, any type of dementia, any type of delirium, or an amnestic disorder due to any general medical condition
- Wechsler Test of Adult Reading standard score <70
- Mini-Mental State Examination score <24
- Current use of scheduled (i.e., prescribed) regular (i.e., daily) psychotropics or other medicines with a high likelihood of sedation & cognitive impairment (e.g., benzodiazepines, clozapine, anticholinergics)
- Currently prescribed stimulants (e.g., methylphenidate) or cognitive enhancers (e.g., donepezil, memantine)
- Active medical illnesses - uncontrolled diabetes, uncontrolled hypertension, uncontrolled thyroid dysfunction, or uncontrolled B12/folate deficiency; central nervous system illness with potential cognitive aspects (Parkinson's, or Huntington's dementia); Cirrhosis with complications (e.g., ascites, encephalopathy, jaundice, gastrointestinal bleeding); Needing acute medical hospitalization from HIV sequelae, such as HIV-related opportunistic infection
- Any history of any type of stroke or brain hemorrhage
- Any history of traumatic brain injury, intracranial pathology (e.g., tumor), or brain surgery
- Currently on probation or parole
- Concurrent participation in another study that medically/administratively interferes with this study
Sites / Locations
- University of California, San Francisco & San Francisco Veterans Affairs Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Cognitive Rehabilitation
Psychoeducation/games
Arm Description
Occupational therapy-based cognitive rehabilitation
Psychoeducation/games
Outcomes
Primary Outcome Measures
Change in cognitive impairment
Global Deficit Score, range 0 (no impairment) to 5 (severe impairment)
Secondary Outcome Measures
Full Information
NCT ID
NCT01684293
First Posted
September 10, 2012
Last Updated
June 28, 2019
Sponsor
University of California, San Francisco
Collaborators
San Francisco Veterans Affairs Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT01684293
Brief Title
Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study
Official Title
Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
July 2013 (undefined)
Primary Completion Date
March 31, 2019 (Actual)
Study Completion Date
March 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
San Francisco Veterans Affairs Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study integrates a model of occupational-therapy based cognitive rehabilitation as part of a comprehensive treatment plan for cocaine abusers. We hypothesize that cognitive impairment and quality of life would improve and that cocaine use would decrease in those participants receiving occupational-therapy based cognitive rehabilitation.
Detailed Description
occupational-therapy based cognitive rehabilitation as part of a comprehensive treatment plan for cocaine abusers
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mild Cognitive Impairment, So Stated, Cocaine Use Disorder
Keywords
Cocaine, Cognitive Impairment, Cognitive Rehabilitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cognitive Rehabilitation
Arm Type
Experimental
Arm Description
Occupational therapy-based cognitive rehabilitation
Arm Title
Psychoeducation/games
Arm Type
Placebo Comparator
Arm Description
Psychoeducation/games
Intervention Type
Behavioral
Intervention Name(s)
Occupational therapy-based cognitive rehabilitation
Intervention Description
Occupational therapy-based cognitive rehabilitation
Intervention Type
Behavioral
Intervention Name(s)
Psychoeducation/games
Intervention Description
Psychoeducation/games
Primary Outcome Measure Information:
Title
Change in cognitive impairment
Description
Global Deficit Score, range 0 (no impairment) to 5 (severe impairment)
Time Frame
baseline through 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18-65
Primary cocaine use disorder (based on DSM-5 criteria) and in at least 3 months of remission
At least mild cognitive impairment, defined as = or > 1.5 standard deviations impairment on any 2 performance-based neurocognitive measures
Needing to change quality of life, defined as self-identifying at least 2 life areas as needing to change on the Drug User Quality of Life Scale
A Veteran at the San Francisco Veterans Affairs Medical Center
Currently receiving weekly drug counseling (individual or group; at least 1 hour/week) through an outpatient substance use disorder treatment program
Exclusion Criteria:
Inability to speak, read, write, and understand English
Inadequate hearing or vision
Concurrent substance use disorder (except tobacco or caffeine) not in at least 3 months of remission
A psychiatric disorder that will interfere with study participation or will make participation hazardous (e.g., psychosis, suicidal or homicidal ideations, severe anxiety)
A depressive disorder classified as severe, defined as a Beck Depression Inventory-II score >29
Current diagnosis of a bipolar disorder needing acute inpatient psychiatric hospitalization
Currently symptomatic from attention-deficit/hyperactivity disorder (DSM-5 criteria)
Any learning disorder, any type of dementia, any type of delirium, or an amnestic disorder due to any general medical condition
Wechsler Test of Adult Reading standard score <70
Mini-Mental State Examination score <24
Current use of scheduled (i.e., prescribed) regular (i.e., daily) psychotropics or other medicines with a high likelihood of sedation & cognitive impairment (e.g., benzodiazepines, clozapine, anticholinergics)
Currently prescribed stimulants (e.g., methylphenidate) or cognitive enhancers (e.g., donepezil, memantine)
Active medical illnesses - uncontrolled diabetes, uncontrolled hypertension, uncontrolled thyroid dysfunction, or uncontrolled B12/folate deficiency; central nervous system illness with potential cognitive aspects (Parkinson's, or Huntington's dementia); Cirrhosis with complications (e.g., ascites, encephalopathy, jaundice, gastrointestinal bleeding); Needing acute medical hospitalization from HIV sequelae, such as HIV-related opportunistic infection
Any history of any type of stroke or brain hemorrhage
Any history of traumatic brain injury, intracranial pathology (e.g., tumor), or brain surgery
Currently on probation or parole
Concurrent participation in another study that medically/administratively interferes with this study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Raj K Kalapatapu, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Francisco & San Francisco Veterans Affairs Medical Center
City
San Francisco
State/Province
California
ZIP/Postal Code
94121
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study
We'll reach out to this number within 24 hrs